IFN-γ could induce proinflammatory activation of hepatic macrophages, and controlling the activation of macrophages through interfering with IFN-γ provides a possible therapeutic target against hepatic fibrosis (70). This evidence concerns the gene IFNG and Hepatic fibrosis.